Clinical Trial Results:
A randomized, controlled, multicentre trial of collateral damage on the intestinal microbiota inferred by cefotaxime versus temocillin in patients receiving empirical treatment for febrile urinary tract infections
Summary
|
|
EudraCT number |
2015-003898-15 |
Trial protocol |
SE |
Global completion date |
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
21 May 2021
|
First version publication date |
21 May 2021
|
Other versions |
|
Summary report(s) |
Temocillin versus cefotaxime in adults with febrile urinary tract infection: a randomised multicentre clinical trial on effect and collateral damage on intestinal microbiota |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.